Navigation Links
3SBio Inc. Announces Third Quarter 2008 Results
Date:11/10/2008

SHENYANG, China, Nov. 10 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the third quarter ended September 30, 2008.

Third Quarter 2008 Financial Highlights:

-- Total net revenues increased 21.6% over the third quarter 2007 to

RMB68.2 million (US$10.0 million).

-- Net revenue from recombinant human erythropoietin ("EPO") products,

marketed under the EPIAO brand, increased 17.5% over the third quarter

2007 to RMB42.7 million (US$6.3 million).

-- Net revenue from protein-based therapeutic recombinant human

thrombopoietin ("TPO") products, marketed under the TPIAO brand

increased 39.3% over the third quarter 2007 to RMB19.7 million (US$2.9

million).

-- Operating income increased 21.4% over the third quarter 2007 to RMB20.7

million (US$3.1 million).

-- One-time impairment loss of approximately RMB19.1 million (US$2.8

million) for the third quarter 2008. This impairment loss was related

to a US$3.0 million aggregate principal amount of Floating Rate Notes,

which are linked to the credit of Lehman Brothers Holdings Inc. and

mature on January 21, 2009, subject to certain conditions.

-- Net income decreased 92.3% over the third quarter 2007 to RMB1.9

million (US$0.3 million).

-- Net income per American depositary share ("ADS") for the third quarter

2008 was RMB0.09 (US$0.01) compared with RMB1.11 (US$0.15) for the

third quarter 2007.

Nin
'/>"/>

SOURCE 3SBio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. 3SBio Inc. Files for SFDA Approval of NuLeusin
2. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
3. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
4. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
5. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
6. 3SBio Inc. Announces Results of Annual General Meeting
7. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. 3SBio Inc. to Hold Annual General Meeting
9. 3SBio Inc. Announces Second Quarter 2008 Results
10. 3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008
11. 3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Clinovo Staffing Solutions will ... held in Orlando, FL on May 17-20th, 2015. ... Leslie Kolman, Manager of Staffing Solutions, will present Clinovo’s ... Booth #17. , “We are excited to be ... Says Trisha Heredia, Senior Director of Staffing Solutions at ...
(Date:4/29/2015)... USA (PRWEB) April 29, 2015 ... sensing, and imaging on the East Coast, reaffirmed its ... managers, researchers, applications developers, and industry suppliers to meet ... imaging for multiple applications. , The event included 55 ... commercial and scientific sensing and imaging -- and an ...
(Date:4/29/2015)... 2015 Cambrex Corporation (NYSE: CBM ) announced ... Friday, May 1, 2015 before the market opens. , ... host a conference call to discuss the financial results. First ... , Friday, May 1, 2015 at 8:30 a.m. Eastern ... U.S.1-719-325-2454 for International  Passcode:  7993632 Dial-in Replay: ...
(Date:4/29/2015)... Gene therapy can clip out genetic material linked to ... human cardiac cells, according to a study led by researchers ... at Mount Sinai. The study is published in the April ... small random, changes in the genetic code making up genes, ... patients with heart failure,” says Roger J. Hajjar, MD, Director ...
Breaking Biology Technology:Clinovo Exhibits at the 2015 PharmaSUG Annual Conference on May 17-20th in Orlando, FL 2Clinovo Exhibits at the 2015 PharmaSUG Annual Conference on May 17-20th in Orlando, FL 3SPIE DSS provides venue for collaboration vital to research, applications advances 2SPIE DSS provides venue for collaboration vital to research, applications advances 3SPIE DSS provides venue for collaboration vital to research, applications advances 4Gene Therapy Clips Out Heart Failure Causing Gene Mutations 2Gene Therapy Clips Out Heart Failure Causing Gene Mutations 3Gene Therapy Clips Out Heart Failure Causing Gene Mutations 4
... (Nasdaq:,CEPH) today announced that the U.S. Food and ... Drug Application (sNDA) for,FENTORA(R) (fentanyl buccal tablet) [C-II] ... with chronic pain. In,addition, the FDA notified the ... on May 6, 2008, to consider this application., ...
... AMDL, Inc. (Amex:,ADL), headquartered in Tustin, ... China, through its wholly owned subsidiary Jade,Pharmaceutical ... together,with Jade, engages in the development, manufacture ... diagnostic products. It today,announced that more than ...
... Jan. 25 ImaRx Therapeutics,Inc. (Nasdaq: IMRX ... Administration,(FDA) has approved the company,s most current lot ... first lot to be released with extended,expiration dating. ... thrombolytic or clot-dissolving agent indicated,for the treatment of ...
Cached Biology Technology:Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application 2Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application 3AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000 2ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating 2ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating 3
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:4/6/2015)... Conn. , Apr. 6, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/143028 for ... COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces a ... payments. This patent surrounds the use of miniature ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... Mass. Researchers at the University of Massachusetts Medical School ... is implicated in 20 percent of inherited cases of amyotrophic ... part in sporadic forms of the disease. Discovery of this ... of Nature Neuroscience . While the SOD1 gene ...
... American Academy of Ophthalmology (AAO) - Middle East-Africa ... report on beta carotene,s ability to improve ... The AAO-MEACO meetingthe world,s largest, most comprehensive ophthalmic ... at McCormick Place, Chicago. 9-cis Beta-Carotene Mat ...
... often compared to a book. However, it is not so much ... like a cookbook. The cell reads only those recipes which are ... ,reading, in the book of the cell means creating RNA copies ... The cell uses highly complex, sophisticated regulatory mechanisms to make ...
Cached Biology News:UMMS researchers identify protein associated with sporadic ALS 2UMMS researchers identify protein associated with sporadic ALS 3A mystery solved: How genes are selectively silenced 2
Ezrin/Radixin/Moesin Antibody...
Ezrin/Radixin/Moesin Antibody...
ABCA1 Immunogen: Mouse ABCA1-expressing HeLa stable transfectants. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
Biology Products: